Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
1
Institute for Design and Control of Mechatronical Systems, Johannes Kepler University Linz, 4040 Linz, Austria
2
Science & Co, 41462 Neuss, Germany
3
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, 89081 Ulm, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Biosensors 2018, 8(2), 50; https://doi.org/10.3390/bios8020050
Received: 13 April 2018
/
Revised: 11 May 2018
/
Accepted: 14 May 2018
/
Published: 18 May 2018
(This article belongs to the Special Issue Continuous Glucose Monitoring)
Systems for continuous glucose monitoring (CGM) are evolving quickly, and the data obtained are expected to become the basis for clinical decisions for many patients with diabetes in the near future. However, this requires that their analytical accuracy is sufficient. This accuracy is usually determined with clinical studies by comparing the data obtained by the given CGM system with blood glucose (BG) point measurements made with a so-called reference method. The latter is assumed to indicate the correct value of the target quantity. Unfortunately, due to the nature of the clinical trials and the approach used, such a comparison is subject to several effects which may lead to misleading results. While some reasons for the differences between the values obtained with CGM and BG point measurements are relatively well-known (e.g., measurement in different body compartments), others related to the clinical study protocols are less visible, but also quite important. In this review, we present a general picture of the topic as well as tools which allow to correct or at least to estimate the uncertainty of measures of CGM system performance.
View Full-Text
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Schrangl, P.; Reiterer, F.; Heinemann, L.; Freckmann, G.; Del Re, L. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials. Biosensors 2018, 8, 50. https://doi.org/10.3390/bios8020050
AMA Style
Schrangl P, Reiterer F, Heinemann L, Freckmann G, Del Re L. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials. Biosensors. 2018; 8(2):50. https://doi.org/10.3390/bios8020050
Chicago/Turabian StyleSchrangl, Patrick, Florian Reiterer, Lutz Heinemann, Guido Freckmann, and Luigi Del Re. 2018. "Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials" Biosensors 8, no. 2: 50. https://doi.org/10.3390/bios8020050
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
